Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Role for the epidermal growth factor receptor in neurofibromatosis-related peripheral nerve tumorigenesis.

Ling BC, Wu J, Miller SJ, Monk KR, Shamekh R, Rizvi TA, Decourten-Myers G, Vogel KS, DeClue JE, Ratner N.

Cancer Cell. 2005 Jan;7(1):65-75.

2.

Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.

Gottfried ON, Viskochil DH, Fults DW, Couldwell WT.

Neurosurgery. 2006 Jan;58(1):1-16; discussion 1-16. Review.

PMID:
16385324
4.

It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.

Viskochil DH.

J Clin Invest. 2003 Dec;112(12):1791-3. Review.

5.

Regulation of Schwann cell proliferation: mechanisms involved in peripheral nerve development.

Eccleston PA.

Exp Cell Res. 1992 Mar;199(1):1-9. Review. No abstract available.

PMID:
1735450
6.
7.
8.

Tumor microenvironment and neurofibromatosis type I: connecting the GAPs.

Le LQ, Parada LF.

Oncogene. 2007 Jul 12;26(32):4609-16. Epub 2007 Feb 12. Review.

9.

How does the Schwann cell lineage form tumors in NF1?

Carroll SL, Ratner N.

Glia. 2008 Nov 1;56(14):1590-605. doi: 10.1002/glia.20776. Review.

10.

Neurofibromatosis.

McClatchey AI.

Annu Rev Pathol. 2007;2:191-216. Review.

PMID:
18039098
11.

Plexiform neurofibroma genesis: questions of Nf1 gene dose and hyperactive mast cells.

Staser K, Yang FC, Clapp DW.

Curr Opin Hematol. 2010 Jul;17(4):287-93. doi: 10.1097/MOH.0b013e328339511b. Review.

12.

NF1 tumor suppressor gene function: narrowing the GAP.

Cichowski K, Jacks T.

Cell. 2001 Feb 23;104(4):593-604. Review. No abstract available.

13.

Neurofibromatosis type 1 (NF1): diagnosis and management.

Ferner RE, Gutmann DH.

Handb Clin Neurol. 2013;115:939-55. doi: 10.1016/B978-0-444-52902-2.00053-9. Review.

PMID:
23931823
14.

Neurofibromatosis 1: closing the GAP between mice and men.

Dasgupta B, Gutmann DH.

Curr Opin Genet Dev. 2003 Feb;13(1):20-7. Review.

PMID:
12573431
15.

Mast cells and the neurofibroma microenvironment.

Staser K, Yang FC, Clapp DW.

Blood. 2010 Jul 15;116(2):157-64. doi: 10.1182/blood-2009-09-242875. Epub 2010 Mar 16. Review.

16.

The role of the immune system in neurofibromatosis type 1-associated nervous system tumors.

Karmakar S, Reilly KM.

CNS Oncol. 2017 Jan;6(1):45-60. doi: 10.2217/cns-2016-0024. Epub 2016 Dec 21. Review.

PMID:
28001089
17.

Neurofibroma development in NF1--insights into tumour initiation.

Parrinello S, Lloyd AC.

Trends Cell Biol. 2009 Aug;19(8):395-403. doi: 10.1016/j.tcb.2009.05.003. Epub 2009 Jul 15. Review.

PMID:
19615906
18.

How Schwann cells facilitate cancer progression in nerves.

Deborde S, Wong RJ.

Cell Mol Life Sci. 2017 Dec;74(24):4405-4420. doi: 10.1007/s00018-017-2578-x. Epub 2017 Jun 19. Review.

PMID:
28631007
19.

Antiangiogenesis in neurofibromatosis 1.

Kurtz A, Martuza RL.

J Child Neurol. 2002 Aug;17(8):578-84; discussion 602-4, 646-51. Review.

PMID:
12403556

Supplemental Content

Support Center